Study to find out the optimal dose of Caffeine in the combination tablet of Naproxen Sodium and Caffeine in patients experiencing moderate to severe pain after having wisdom teeth removed - Trial 2019-003513-33
Access comprehensive clinical trial information for 2019-003513-33 through Pure Global AI's free database. This phase not specified trial is sponsored by Bayer HealthCare LLC and is currently status unknown. The study focuses on Pain, Postoperative.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2019-003513-33
Trial Details
EU Clinical Trials Register • 2019-003513-33
Study to find out the optimal dose of Caffeine in the combination tablet of Naproxen Sodium and Caffeine in patients experiencing moderate to severe pain after having wisdom teeth removed
Study Focus
Sponsor & Location
Bayer HealthCare LLC
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Dental examination
During surgical operation
During surgical operation
During surgical operation
Presence of dental prosthetic device (complete)(partial)
Data Source
EU Clinical Trials Register
2019-003513-33
Non-Device Trial